CRWEWorld's Hottest Stocks Now provides information only. It is not meant to be a recommendation/offer to buy or to sell securities. DYODD
Las Vegas, NV
Joined January 2010
- Tweets80K
- Following1.6K
- Followers2.8K
- Likes38
Valneva Reports Sustained 94% Seroresponse Five Years After a Single Dose of Chikungunya Vaccine IXCHIQ $VALN, #Valneva, #VLA crweworld.com/article/news-p…
14
Nano-X Imaging OKs Cost Reduction and Operational Efficiency Measures - Intends to focus on four priorities $NNOX, #NanoXImaging, #NanoX crweworld.com/article/news-p…
1
115
AAR inks multi-year radome repair deal with Airbus Avionics $AIR, #AARCorp, #AAR, #AirbusAvionics, #Airbus crweworld.com/article/news-p…
68
Ur-Energy Reports Q3 2026 Results - Sales Increase Significantly Year Over Year $URG, $URE.CA, #UrEnergy crweworld.com/article/news-p…
52
Microvast Reports Q3 2026 Results - Material decline in sales, gross margin and operating performance during the quarter significantly constrains its liquidity $MVST, #Microvast crweworld.com/article/news-p…
1
343
Key Date Approaching for Wrap Technologies Shareholders $WRAP, #WrapTechnologies, #WrapTech crweworld.com/article/news-p…
63
The Real Numbers Behind USA Rare Earth Revealed $USAR, #USARareEarth, #RareEarth crweworld.com/article/news-p…
122
Black Diamond Therapeutics to Reveal Updated Silevertinib Phase 2 Data and FDA Feedback Supporting Clear Phase 3 Path to Potential Accelerated Approval in 1L EGFR-NCM Non-Small Cell Lung Cancer (NSCLC) $BDTX, #BlackDiamondTherapeutics, #BlackDiamondTx crweworld.com/article/news-p…
93
Altimmune: RECLAIM Phase 2 study results show treatment with pemvidutide led to significant reduction in heavy drinking days and improved outcomes on other key clinical measures in patients with alcohol use disorder $ALT, #Altimmune crweworld.com/article/news-p…
68
Kyverna Therapeutics: KYSA-8 registrational data underscores the unique potential of miv-cel to liberate patients with stiff person syndrome from life-long disease burden and chronic immunotherapy use $KYTX, #KyvernaTherapeutics, #KyvernaTx, #Kyverna crweworld.com/article/news-p…
83
Eli Lilly: Foundayo (orforglipron) significantly reduced obstructive sleep apnea severity, reinforcing its potential to improve health beyond weight loss $LLY, #EliLilly, #Lilly crweworld.com/article/news-p…
44
CRISPR Therapeutics: Phase 1b Data for CTX310 Shows Reductions in ANGPTL3 and Triglycerides in Patients with Severe Hypertriglyceridemia $CRSP, #CRISPRTherapeutics, #CRISPRTx, #CRISPR crweworld.com/article/news-p…
89
Aptevo's next-generation immunotherapies show the ability to kill cancer cells even when tumors suppress the immune system $APVO, #AptevoTherapeutics, #AptevoTx, #Aptevo crweworld.com/article/news-p…
54
Celcuity: FDA OKs sNDA for REVTORPYK (gedatolisib) for HR+/HER2-, PIK3CA Mutant Locally Advanced or Metastatic Breast Cancer $CELC, #Celcuity crweworld.com/article/news-p…
56
The Real Numbers Behind Lucid Revealed $LCID, #LucidGroup, #LucidMotors, #Lucid crweworld.com/article/news-p…
61
Rocket Lab Lands $515M+ in Neutron Launch Deals from Constellation Operators in Q3 $RKLB, #RocketLab crweworld.com/article/news-p…
122
Plug Power Reports Q3 Revenue of ~$201M, Significant YoY Gross Margin Improvement, Record-Low Net Cash Usage with ~54% reduction sequentially $PLUG, #PlugPower crweworld.com/article/news-p…
SCHMID Group Secures Key Wet-Process Equipment Order for South Asia’s First Glass Core Substrate Manufacturing Facility $SHMD, #SCHMIDGroup, #SCHMID crweworld.com/article/news-p…
112
Maris-Tech Reveals Record Order Backlog of Approximately $11M $MTEK, #MarisTech crweworld.com/article/news-p…
58